A leucine-supplemented diet improved protein content of skeletal muscle in young tumor-bearing rats

Cancer cachexia induces host protein wastage but the mechanisms are poorly understood. Branched-chain amino acids play a regulatory role in the modulation of both protein synthesis and degradation in host tissues. Leucine, an important amino acid in skeletal muscle, is higher oxidized in tumor-bearing animals. A leucine-supplemented diet was used to analyze the effects of Walker 256 tumor growth on body composition in young weanling Wistar rats divided into two main dietary groups: normal diet (N, 18% protein) and leucine-rich diet (L, 15% protein plus 3% leucine), which were further subdivided into control (N or L) or tumor-bearing (W or LW) subgroups. After 12 days, the animals were sacrificed and their carcass analyzed. The tumor-bearing groups showed a decrease in body weight and fat content. Lean carcass mass was lower in the W and LW groups (W = 19.9 ± 0.6, LW = 23.1 ± 1.0 g vs N = 29.4 ± 1.3, L = 28.1 ± 1.9 g, P < 0.05). Tumor weight was similar in both tumor-bearing groups fed either diet. Western blot analysis showed that myosin protein content in gastrocnemius muscle was reduced in tumor-bearing animals (W = 0.234 ± 0.033 vs LW = 0.598 ± 0.036, N = 0.623 ± 0.062, L = 0.697 ± 0.065 arbitrary intensity, P < 0.05). Despite accelerated tumor growth, LW animals exhibited a smaller reduction in lean carcass mass and muscle myosin maintenance, suggesting that excess leucine in the diet could counteract, at least in part, the high host protein wasting in weanling tumor-bearing rats.1589159

The Southern Ocean Exchange: Porous boundaries between humpback whale breeding populations in southern polar waters

Humpback whales (Megaptera novaeangliae) are a cosmopolitan species and perform long annual migrations between low-latitude breeding areas and high-latitude feeding areas. Their breeding populations appear to be spatially and genetically segregated due to long-term, maternally inherited fidelity to natal breeding areas. In the Southern Hemisphere, some humpback whale breeding populations mix in Southern Ocean waters in summer, but very little movement between Pacific and Atlantic waters has been identified to date, suggesting these waters constituted an oceanic boundary between genetically distinct populations. Here, we present new evidence of summer co-occurrence in the West Antarctic Peninsula feeding area of two recovering humpback whale breeding populations from the Atlantic (Brazil) and Pacific (Central and South America). As humpback whale populations recover, observations like this point to the need to revise our perceptions of boundaries between stocks, particularly on high latitude feeding grounds. We suggest that this “Southern Ocean Exchange” may become more frequent as populations recover from commercial whaling and climate change modifies environmental dynamics and humpback whale prey availability

Increased oxidative stress in the placenta tissue and cell culture of tumour-bearing pregnant rats

AbstractPlacental dysfunction leads to foetal damage, which jeopardises the exchange between the maternal and foetal systems. We evaluated the effects of tumour growth on the activity of antioxidant enzymes and oxidative stress in placental tissue and cell culture from tumour-bearing pregnant rats compared to non-tumour-bearing pregnant rats that were ascitic fluid injected. Ascitic fluid is obtained from Walker tumour-bearing rats and contains a cytokine called Walker factor (WF), which is a molecule similar to proteolysis-inducing factor (PIF), and induces changes in protein metabolism and oxidative stress. Pregnant Wistar rats were distributed into control (C), tumour-bearing (W) and ascitic fluid injected (A) groups and were sacrificed on days 16, 19 and 21 of pregnancy to analyse the profile of enzyme activities (glutathione-S-transferase (GST), catalase (CAT), alkaline phosphatase (AP)) and malondialdehyde (MDA) content in placental tissue. Meanwhile, placenta samples from all groups were obtained on day 21, placed in primary culture and treated with WF for 72 h. The presence of tumour or ascitic fluid reduced the protein content of the placental tissue. On day 16 there was a significant reduction in AP activity in W rats, and on day 19, CAT activity and MDA content significantly increased. These results indicate that the presence of cancer decreased antioxidant enzyme capacity in the placenta, increasing the amount of oxidation in these cells, which may contribute to irreversible placental damage and compromisefoetal development. WF treatment induces similar changes in placental cells in primary culture, resulting in less cell viability and increased oxidative stress. These results indicate that WF, provided by the tumour or inoculation of ascitic fluid, has negative effects on placental homeostasis, which impairs foetal health

Dietary Fatty Acid Quality Affects Ar And Pparγ Levels And Prostate Growth

BACKGROUND. Fatty acids are among the most important nutritional factors associated with the ethiopathogenesis of prostate cancer, therefore the main objective of this work was to evaluate the effect of quality of fatty acid on the rat ventral prostate growth, tissue organization, and expression of androgen receptor (AR) and peroxisome proliferation activator receptor g (PPARγ). METHODS. Wistar rats were distributed into five groups, which were fed isocaloric normolipidic diets containing soybean oil (7% Control), linseed (7% or 3.5% linseed plus 3.5% soybean oil) and rendered pork fat (7% or 3.5% lard plus 3.5% soybean oil) for 10 weeks after weaning. RESULTS. At the end of treatment, the experiments demonstrated that lard and linseed oil caused opposite effects on prostatic growth. While the lard promoted an increase in prostatic weight associated to epithelial hyperplasia (confirmed by stereology); the linseed resulted in a significantly lighter organ. Immunohistochemistry and Western blotting demonstrated increased expression of AR and PPARγ in groups fed with lard diet, while linseed oil promoted a decrease. CONCLUSIONS. Prostatic growth is influenced by dietary fatty acids with concurrent variation in the expression of AR and PPARγ. PPARγ might represent the link between diet and prostate growth and AR expression and function. Since the levels of testosterone were altered it is also possible that prostatic changes are secondary to systemic effects of the diet. © 2009 Wiley-Liss, Inc.695548558Dhom, G., Epidemiologic aspects of latent and clinically manifest carcinoma of the prostate (1983) Journal of Cancer Research and Clinical Oncology, 106 (3), pp. 210-218Chaudry, A., McClinton, S., Moffat, L.E.F., Wahle, K.W.J., Essential fatty acids distribution in the plasma and tissue phospholipids of patients with benign and malignant prostatic disease (1991) Br J Cancer, 64, pp. 1157-1160Rowley, K.H., Mason, M.D., The aetiology and patogenesis of prostate cancer (1997) Clin Oncol R Coll Radiol, 9, pp. 213-218Mamalakis, G., Kafatos, A., Karagelopoulos, N., Andrikolopoulos, N., Daskalopoulos, G., Kranidis, A., Prostate cancer vs hiperplasia: Relationships with prostatic and adipose tissue fatty acid composition (2002) Prostagl Leukotr Essent Fatty Acids, 66, pp. 467-477Hankey, B.F., Feuer, E.J., Clegg, L.X., Hayes, R.B., Legler, J.M., Prorok, P.C., Ries, L.A., Kaplan, R.S., Cancer surveillance series: Interpreting trends in prostate cancer. Part I. Evidence of the effects of screening in recent prostate cancer incidence, mortality, and survival rates (1999) J Natl Cancer Inst, 91, pp. 1017-1024Fleshner, N., Bagnell, P.S., Klotz, L., Venkateswaran, V., Kristal, A.R., Thompson, I.M., Klein, E., Ford, L.G., Dietary fat and prostate cancer (2004) Journal of Urology, 171 (2), pp. S19-S24. , DOI 10.1097/01.ju.0000107838.33623.19Shennan, D.H., Bishop, O.S., Diet and the mortality from malignant disease in 32 countries (1974) West Indian Med J, 23, pp. 44-53Blair, A., Fraumeni Jr., J.F., Geographic patterns of prostate cancer in the United States (1978) Journal of the National Cancer Institute, 61 (6), pp. 1379-1384Carroll, K.K., Khor, H.T., Dietaty fat in relation to tumorigenesis (1975) Prog Biochem Pharmacol, 10, pp. 308-353Kolonel, L.N., Nomura, A.M., Cooney, R.V., Dietary fat and prostate cancer: Current status (1999) J Natl Cancer Inst, 91, pp. 414-428Myers, C.E., Ghosh, J., Lipoxygenase inhibition in prostate cancer (1999) European Urology, 35 (5-6), pp. 395-398. , DOI 10.1159/000019915Zhu, Y.S., Katz, M.D., McGinley, I., Lessons from human genetic models (1998) Bailleres Clin Endocrinol Metab, 12, pp. 83-113Cunha, G.R., Donjacour, A.A., Cooke, P.S., Mee, S., Bigsby, R.M., Higgins, S.J., Sugimura, Y., The endocrinology and developmental biology of the prostate (1987) Endocr Rev, 8, pp. 338-362Ross, R.K., Henderson, B.E., Do diets and androgens alter prostate cancer risk via a common etiologic pathway? (1994) J Natl Cancer Inst, 86, pp. 252-254Dorgan, J.F., Judd, J.T., Longcope, C., Brown, C., Schatzkin, A., Clevidence, B.A., Campbell, W.S., Taylor, P.R., Effects of dietary fat and fiber on plasma and urine androgens and estrogens in men: A controlled feeding study (1996) Am J Clin Nutr, 64, pp. 850-855Issemann, I., Green, S., Activation of a member of the steroid hormone receptor superfamily by peroxisome proliferators (1990) Nature, 347 (6294), pp. 645-650. , DOI 10.1038/347645a0Zhang, B., Marcus, S.L., Sajjadi, F.G., Alvares, K., Reddy, J.K., Subramani, S., Rachubinski, R.A., Capone, J.P., Identification of a peroxisome proliferator-responsive element upstream of the gene encoding rat peroxisomal enoyl-CoA hydratase 3-hydroxyacyl-CoA- dehydrogenase (1992) Proc Natl Acad Sci USA, 89, pp. 7541-7545Krey, G., Braissant, O., L'Horset, F., Kalkhoven, E., Perroud, M., Parker, M.G., Wahli, W., Fatty acids eicosanoids are ligands for peroxisome proliferator-activated receptors by coactivator-dependent receptor ligand assay (1997) Mol Endocrinol, 11, pp. 770-791Segawa, Y., Yoshimura, R., Hase, T., Hase, T., Nakatani, T., Wada, S., Kawahito, Y., Sano, H., Expression of peroxisome proliferator-activated receptor (PPAR) in human prostate cancer (2002) Prostate, 51, pp. 108-116Willson, T.M., Lambert, M.H., Kliewer, S.A., Peroxisome proliferator-activated receptor gamma and metabolic disease (2001) Annual Review of Biochemistry, 70, pp. 341-367. , DOI 10.1146/annurev.biochem.70.1.341Sporn, M.B., Suh, N., Mangelsdorf, D.J., Prospects for prevention and treatment of cancer with selective PPARgamma modulators (SPARMs) (2001) Trends in Molecular Medicine, 7 (9), pp. 395-400. , DOI 10.1016/S1471-4914(01)02100-1, PII S1471491401021001Rosen, E.D., Spiegelman, B.M., PPARgamma: A Nuclear Regulator of Metabolism, Differentiation, and Cell Growth (2001) Journal of Biological Chemistry, 276 (41), pp. 37731-37734Nwankwo, J.O., Robbins, M.E.C., Peroxisome proliferator-activated receptor-gamma expression in human malignant and normal brain, breast and prostate-derived cells (2001) Prostaglandins Leukotrienes and Essential Fatty Acids, 64 (4-5), pp. 241-245. , DOI 10.1054/plef.2001.0266Han, S., Roman, J., Peroxisome proliferator-activated receptor gamma: A novel target for cancer therapeutics? (2007) Anticancer Drugs, 18 (3), pp. 237-244Mueller, E., Smith, M., Sarraf, P., Kroll, T., Aiyer, A., Kaufman, D.S., Oh, W., Kantoff, P.W., Effects of ligand activation of peroxisome proliferator-activated receptor g human prostate cancer (2000) Proc Natl Acad Sci USA, 97, pp. 10990-10995Buyukbabani, N., Mitchell, S.H., Tindall, D.J., Young, C.Y.F., Non-apoptotic cell death associated with S-phase arrest of prostate cancer cells via peroxisome proliferator-activated receptor γ ligand, 15-deoxy-12,14-prostaglandin J12 (2000) Cell Growth Differ, 11, pp. 49-61Li, W.-D., Lee, J.H., Price, R.A., The peroxisome proliferator-activated receptor gamma2 Pro12Ala mutation is associated with early onset extreme obesity and reduced fasting glucose (2000) Molecular Genetics and Metabolism, 70 (2), pp. 159-161. , DOI 10.1006/mgme.2000.2999Reeves, P.G., Nielsen, F.H., Fahey Jr., G.C., AIN-93 purified diets for laboratory rodents: Final report of the American Institute of Nutrition ad hoc writing committee on the reformulation of the AIN-76A rodent diet (1993) J Nutr, 123, pp. 1939-1951Kondo, Y., Homma, Y., Aso, Y., Kakizoe, T., Promotional effect of two-generation exposure to a high-fat diet on prostate carcinogenesis in ACI/Seg rats (1994) Cancer Research, 54 (23), pp. 6129-6132Wang, Y., Corr, J.G., Thaler, H.T., Tao, Y., Fair, W.R., Heston, W.D., Decreased growth of established human prostate LNCaP tumors in nude mice fed a low-fat diet (1995) J Natl Cancer Inst, 87, pp. 1456-1462Garcia-Florez, M., Oliveira, C.A., Carvalho, H.F., Early effects of estrogen on the rat ventral prostate (2005) Brazilian Journal of Medical and Biological Research, 38 (4), pp. 487-497Vilamaior, P.S.L., Taboga, S.R., Carvalho, H.F., Postnatal growth of the ventral prostate in Wistar rats: A stereological and morphometrical study (2006) Anat Rec, 288 A, pp. 885-892Fritz, W.A., Wang, J., Eltoum, I.-E., Lamartiniere, C.A., Dietary genistein down-regulates androgen and estrogen receptor expression in the rat prostate (2002) Molecular and Cellular Endocrinology, 186 (1), pp. 89-99. , PII S0303720701006633Gad, S.C., Weil, C.S., Statistic for toxicologists (1994) Principles and Methods of Toxicology, pp. 221-274. , Wallace H, editor. New York: Raven PressGiles, G., Ireland, P., Diet, nutrition and prostate cancer (1997) International Journal of Cancer, 72 (SUPPL.), pp. 13-17Cai, X., Haleem, R., Oram, S., Cyriac, J., Jiang, F., Grayhack, J.T., Kozlowski, J.M., Wang, Z., High fat diet increases the weight of rat ventral prostate (2001) Prostate, 49 (1), pp. 1-8. , DOI 10.1002/pros.1112Cai, G., Huang, H., Shapiro, E., Zhou, H., Yeh, S., Melamed, J., Greco, M.A., Lee, P., Expression of androgen receptor associated protein 55 (ARA55) in the developing human fetal prostate (2005) Journal of Urology, 173 (6), pp. 2190-2193. , DOI 10.1097/01.ju.0000158119.34126.70Wahle, K.W., Heys, S.D., Cell signal mechanisms, conjugated linoleic acids (CLAs) and anti-tumorigenesis (2002) Prostagl Leukotr Essent Fatty Acids, 67, pp. 183-186Bidoli, E., Talamini, R., Bosetti, C., Negri, E., Maruzzi, D., Montella, M., Franceschi, S., La Vecchia, C., Macronutrients, fatty acids, cholesterol and prostate cancer risk (2005) Ann Oncol, 16, pp. 152-157Feldman, B.J., Feldman, D., The development of androgen-independent prostate cancer (2001) Nature Reviews Cancer, 1 (1), pp. 34-45Sciarra, F., Toscano, V., Role of estrogens in human benign prostatic hyperplasia (2000) Archives of Andrology, 44 (3), pp. 213-220Håå G, P., Bektic, J., Bartsch, G., Klocker, H., Eder, I.E., Androgen receptor down regulation by small interference RNA induces cell growth inhibition in androgen sensitive as well as in androgen independent prostate cancer cells (2005) J Steroid Biochem Mol Biol, 96, pp. 251-258Freeman, V.L., Meydani, M., Hur, K., Flanigan, R.C., Inverse association between prostatic polyunsaturated fatty acid and risk of locally advanced prostate carcinoma (2004) Cancer, 101 (12), pp. 2744-2754. , DOI 10.1002/cncr.20676Bravi, F., Bosetti, C., Dal Maso, L., Talamini, R., Montella, M., Negri, E., Ramazzotti, V., La Vecchia, C., Food groups and risk of benign prostatic hyperplasia (2006) Urology, 67 (1), pp. 73-79. , DOI 10.1016/j.urology.2005.07.030, PII S009042950501126XHardman, W.E., (n-3) fatty acids and cancer therapy (2004) J Nutr, 134 (12 SUPPL.), pp. 3427S-3430SKota, B.P., Huang, T.H.-W., Roufogalis, B.D., An overview on biological mechanisms of PPARs (2005) Pharmacological Research, 51 (2), pp. 85-94. , DOI 10.1016/j.phrs.2004.07.012, PII S104366180400194XSubbarayan, V., Sabichi, A.L., Kim, J., Llansa, N., Logothetis, C.J., Lippman, S.M., Menter, D.G., Differential peroxisome proliferator-activated receptor-γ isoform expression and agonist effects in normal and malignant prostate cells (2004) Cancer Epidemiology Biomarkers and Prevention, 13 (11), pp. 1710-1716Cury-Boaventura, F.M., Kanunfre, C.C., Gorjão, R., Martins De Lima, T., Curi, R., Mechanisms involved in Jurkat cell death induced by oleic and linoleic acids (2006) Clin Nutr, 25, pp. 1004-1014Sampath, H., Ntambi, J.M., Polyunsaturated fatty acid regulation of gene expression (2004) Nutrition Reviews, 62 (9), pp. 333-339. , DOI 10.1301/nr.2004.sept.333-339Murtaugh, M.A., Ma, K.-N., Caan, B.J., Sweeney, C., Wolff, R., Samowitz, W.S., Potter, J.D., Slattery, M.L., Interactions of peroxisome proliferator-activated receptor, and diet in etiology of colorectal cancer (2005) Cancer Epidemiology Biomarkers and Prevention, 14 (5), pp. 1224-1229. , DOI 10.1158/1055-9965.EPI-04-068

Naringin Inhibits Tumor Growth And Reduces Interleukin-6 And Tumor Necrosis Factor α Levels In Rats With Walker 256 Carcinosarcoma

The flavonoid naringin is a polyphenolic compound that naturally occurs in citrus. Patients with cancer generally present features of malnutrition and cachexia. Levels of the proinflammatory cytokines tumor necrosis factor α (TNF-α) and interleukin-6 (IL-6) are raised in patients with cancer. This study was designed to analyze the in vivo effect of naringin in the therapeutic treatment of rats bearing Walker 256 carcinosarcoma (W256). Rats were treated intraperitoneally with different doses of naringin (10, 25 and 35 mg/kg), for 50 days. At 25 mg/kg, naringin inhibited tumor growth by ∼75%. With this treatment, TNF-α and IL-6 levels decreased (p3.0.CO;2-NSkipworth, R.J.E., Stewart, G.D., Dejong, C.H.C., Preston, T., Fearon, K.C.H., Pathophysiology of cancer cachexia: Much more than host-tumour interaction? (2007) Clinical Nutrition, 26 (6), pp. 667-676. , DOI 10.1016/j.clnu.2007.03.011, PII S0261561407000696Seruga, B., Zhang, H., Bernstein, L.J., Tannock, I.F., Cytokines and their relationship to the symptoms and outcome of cancer (2008) Nat Rev Cancer, 8, pp. 887-899Tisdale, M.J., Metabolic abnormalities in cachexia and anorexia (2000) Nutrition, 16, pp. 1013-1014Tisdale, M.J., Mechanisms of cancer cachexia (2009) Physiol Rev, 89, pp. 381-410Argiles, J.M., Busquets, S., Felipe, A., Lopez-Soriano, F.J., Molecular mechanisms involved in muscle wasting in cancer and ageing: Cachexia versus sarcopenia (2005) International Journal of Biochemistry and Cell Biology, 37 (5 SPEC. ISS.), pp. 1084-1104. , DOI 10.1016/j.biocel.2004.10.003Tang, M.X., Ogawa, K., Asamoto, M., Hokaiwado, N., Seeni, A., Suzuki, S., Takahashi, S., Shirai, T., Protective effects of citrus nobiletin and auraptene in transgenic rats developing adenocarcinoma of the prostate (TRAP) and human prostate carcinoma cells (2007) Cancer Science, 98 (4), pp. 471-477. , DOI 10.1111/j.1349-7006.2007.00417.xLimtrakul, P., Phromnoi, K., Reuter, S., Sung, B., Aggarwal, B.B., A dihydroxy-pentamethoxyflavone from Gardenia obtusifolia suppresses proliferation and promotes apoptosis of tumor cells through modulation of multiple cell signaling pathways (2010) Anticancer Res, 30, pp. 3599-3610Ribeiro, I.A., Ribeiro, M.H.L., Naringin and naringenin determination and control in grapefruit juice by a validated HPLC method (2008) Food Control, 19 (4), pp. 432-438. , DOI 10.1016/j.foodcont.2007.05.007, PII S0956713507001077Ye, H., Xu, H.D., Yu, C.G., Dai, Y.J., Liu, G.Y., Xu, W.P., Yuan, S., Hydroxylation of naringin by Trichoderma harzianum to dramatically improve its antioxidative activity (2009) Enzyme Microb Tech, 45, pp. 282-287Han, S.-S., You, I.-J., Studies on antimicrobial activities and safety of natural naringin in Korea (1988) Korean Soc Mycol, 16, pp. 33-40Kaul, T.N., Middleton Jr., E., Ogra, P.L., Antiviral effect of flavonoids on human viruses (1985) Journal of Medical Virology, 15 (1), pp. 71-79. , DOI 10.1002/jmv.1890150110Martin, M.J., Marhuenda, E., Perez-Guerrero, C., Franco, J.M., Antiulcer effect of naringin on gastric lesions induced by ethanol in rats (1994) Pharmacology, 49 (3), pp. 144-150Kanno, S.-I., Tomizawa, A., Hiura, T., Osanai, Y., Shouji, A., Ujibe, M., Ohtake, T., Ishikawa, M., Inhibitory effects of naringenin on tumor growth in human cancer cell lines and sarcoma S-180-implanted mice (2005) Biological and Pharmaceutical Bulletin, 28 (3), pp. 527-530. , DOI 10.1248/bpb.28.527So, F.V., Guthrie, N., Chambers, A.F., Moussa, M., Carroll, K.K., Inhibition of human breast cancer cell proliferation and delay of mammary tumorigenesis by flavonoids and citrus juices (1996) Nutrition and Cancer, 26 (2), pp. 167-181Le, M.L., Murphy, S.P., Hankin, J.H., Wilkens, L.R., Kolonel, L.N., Intake of flavonoids and lung cancer (2000) Journal of the National Cancer Institute, 92 (2), pp. 154-160Tomasik, P., (2004) Chemical and Functional Properties of Food Saccharides, , Boca Raton: CRC PressBenavente-Garcia, O., Castillo, J., Update on uses and properties of citrus flavonoids: New findings in anticancer, cardiovascular, and anti-inflammatory activity (2008) J Agric Food Chem, 56, pp. 6185-6205Kawaguchi, K., Kikuchi, S., Hasegawa, H., Maruyama, H., Morita, H., Kumazawa, Y., Suppression of lipopolysaccharide-induced tumor necrosis factor-release and liver injury in mice by naringin (1999) European Journal of Pharmacology, 368 (2-3), pp. 245-250. , DOI 10.1016/S0014-2999(98)00867-X, PII S001429999800867XGordon, P.B., Holen, I., Seglen, P.O., Protection by naringin and some other flavonoids of hepatocytic autophagy and endocytosis against inhibition by okadaic acid (1995) J Biol Chem, 270, pp. 5830-5838Camargo, C.A., Da Silva, M.E., Da Silva, R.A., Justo, G.Z., Gomes-Marcondes, M.C., Aoyama, H., Inhibition of tumor growth by quercetin with increase of survival and prevention of cachexia in Walker 256 tumor-bearing rats (2011) Biochem Biophys Res Commun, 406, pp. 638-642Vale, C., Stewart, L., Tierney, J., Trends in UK cancer trials: Results from the UK Coordinating Committee for Cancer Research National Register of Cancer Trials (2005) British Journal of Cancer, 92 (5), pp. 811-814. , DOI 10.1038/sj.bjc.6602425Gomes-Marcondes, M.C.C., Honma, H.N., Areas, M.A., Cury, L., Effect of Walker 256 tumor growth on intestinal absorption of leucine, methionine and glucose in newly weaned and mature rats (1998) Brazilian Journal of Medical and Biological Research, 31 (10), pp. 1345-1348Gomes-Marcondes, M.C., (1994) Influência Da Gestação Sobre O Crescimento Do Câncer e Deste Sobre O Desenvolvimento Fetoplacentário, , Campinas, São Paulo, Brazil: Universidade Estadual de Campinas (UNICAMP), PhD ThesisKaplan, E.L., Meier, P., Nonparametric-estimation from incomplete observations (1958) J Am Stat Assoc, 53, pp. 457-481Mantel, N., Evaluation of survival data and two new rank order statistics arising in its consideration (1966) Cancer Chemother Rep, 50, pp. 163-170Cox, D.R., Regression models and life-tables (1972) J Roy Stat Soc, 34, pp. 187-1120Kawakami, M., Pekala, P.H., Lane, M.D., Cerami, A., Lipoprotein lipase suppression in 3T3-L1 cells by an endotoxin-induced mediator from exudate cells (1982) Proceedings of the National Academy of Sciences of the United States of America, 79 (3 I), pp. 912-916Busquets, S., Deans, C., Figueras, M., Moore-Carrasco, R., Lopez-Soriano, F.J., Fearon, K.C.H., Argiles, J.M., Apoptosis is present in skeletal muscle of cachectic gastro-intestinal cancer patients (2007) Clinical Nutrition, 26 (5), pp. 614-618. , DOI 10.1016/j.clnu.2007.06.005, PII S0261561407001069Inui, A., Cancer anorexia-cachexia syndrome: Are neuropeptides the key? (1999) Cancer Res, 59, pp. 4493-4501Samuels, S.E., Knowles, A.L., Tilignac, T., Debiton, E., Madelmont, J.C., Attaix, D., Protein metabolism in the small intestine during cancer cachexia and chemotherapy in mice (2000) Cancer Res, 60, pp. 4968-497

Effect of Walker 256 tumor growth on intestinal absorption of leucine, methionine and glucose in newly weaned and mature rats

In tumor-bearing rats, most of the serum amino acids are used for synthesis and oxidation processes by the neoplastic tissue. In the present study, the effect of Walker 256 carcinoma growth on the intestinal absorption of leucine, methionine and glucose was investigated in newly weaned and mature rats. Food intake and carcass weight were decreased in newly weaned (NT) and mature (MT) rats bearing Walker 256 tumor in comparison with control animals (NC and MC). The tumor/carcass weight ratio was higher in NT than in MT rats, whereas nitrogen balance was significantly decreased in both as compared to control animals. Glucose absorption was significantly reduced in MT rats (MT = 47.3 ± 4.9 vs MC = 99.8 ± 5.3 nmol min-1 cm-1, Kruskal-Wallis test, P&lt;0.05) but this fact did not hamper the evolution of cancer. There was a significant increase in methionine absorption in both groups (NT = 4.2 ± 0.3 and MT = 2.0 ± 0.1 vs NC = 3.7 ± 0.1 and MC = 1.2 ± 0.2 nmol min-1 cm-1, Kruskal-Wallis test, P&lt;0.05), whereas leucine absorption was increased only in young tumor-bearing rats (NT = 8.6 ± 0.2 vs NC = 7.7 ± 0.4 nmol min-1 cm-1, Kruskal-Wallis test, P&lt;0.05), suggesting that these metabolites are being used for synthesis and oxidation processes by the neoplastic cells, which might ensure their rapid proliferation especially in NT rats

Effect of Walker 256 tumor growth on intestinal absorption of leucine, methionine and glucose in newly weaned and mature rats

In tumor-bearing rats, most of the serum amino acids are used for synthesis and oxidation processes by the neoplastic tissue. In the present study, the effect of Walker 256 carcinoma growth on the intestinal absorption of leucine, methionine and glucose was investigated in newly weaned and mature rats. Food intake and carcass weight were decreased in newly weaned (NT) and mature (MT) rats bearing Walker 256 tumor in comparison with control animals (NC and MC). The tumor/carcass weight ratio was higher in NT than in MT rats, whereas nitrogen balance was significantly decreased in both as compared to control animals. Glucose absorption was significantly reduced in MT rats (MT = 47.3 ± 4.9 vs MC = 99.8 ± 5.3 nmol min-1 cm-1, Kruskal-Wallis test, P&lt;0.05) but this fact did not hamper the evolution of cancer. There was a significant increase in methionine absorption in both groups (NT = 4.2 ± 0.3 and MT = 2.0 ± 0.1 vs NC = 3.7 ± 0.1 and MC = 1.2 ± 0.2 nmol min-1 cm-1, Kruskal-Wallis test, P&lt;0.05), whereas leucine absorption was increased only in young tumor-bearing rats (NT = 8.6 ± 0.2 vs NC = 7.7 ± 0.4 nmol min-1 cm-1, Kruskal-Wallis test, P&lt;0.05), suggesting that these metabolites are being used for synthesis and oxidation processes by the neoplastic cells, which might ensure their rapid proliferation especially in NT rats.1345134